172 related articles for article (PubMed ID: 35466449)
1. Calcium Citrate Versus Calcium Carbonate in the Management of Chronic Hypoparathyroidism: A Randomized, Double-Blind, Crossover Clinical Trial.
Naciu AM; Tabacco G; Bilezikian JP; Santonati A; Bosco D; Incognito GG; Gaspa G; Manfrini S; Falchetti A; Trimboli P; Mazziotti G; Napoli N; Sanson G; Cesareo R; Vescini F; Palermo A
J Bone Miner Res; 2022 Jul; 37(7):1251-1259. PubMed ID: 35466449
[TBL] [Abstract][Full Text] [Related]
2. Risk of calcium oxalate nephrolithiasis after calcium or combined calcium and calcitriol supplementation in postmenopausal women.
Domrongkitchaiporn S; Ongphiphadhanakul B; Stitchantrakul W; Piaseu N; Chansirikam S; Puavilai G; Rajatanavin R
Osteoporos Int; 2000; 11(6):486-92. PubMed ID: 10982163
[TBL] [Abstract][Full Text] [Related]
3. Initial Assessment and Monitoring of Patients with Chronic Hypoparathyroidism: A Systematic Current Practice Survey.
Van Uum S; Shrayyef M; M'Hiri I; Dandurand K; Ali DS; Bilezikian JP; Collins MT; Mannstadt M; Rubin MR; Siggelkow H; Tabacco G; Tay YD; Vokes T; Winer KK; Yao L; Guyatt G; Rejnmark L; Khan AA
J Bone Miner Res; 2022 Dec; 37(12):2630-2641. PubMed ID: 36066096
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and Safety of Parathyroid Hormone Replacement With TransCon PTH in Hypoparathyroidism: 26-Week Results From the Phase 3 PaTHway Trial.
Khan AA; Rubin MR; Schwarz P; Vokes T; Shoback DM; Gagnon C; Palermo A; Marcocci C; Clarke BL; Abbott LG; Hofbauer LC; Kohlmeier L; Pihl S; An X; Eng WF; Smith AR; Ukena J; Sibley CT; Shu AD; Rejnmark L
J Bone Miner Res; 2023 Jan; 38(1):14-25. PubMed ID: 36271471
[TBL] [Abstract][Full Text] [Related]
5. Risk of calcium oxalate nephrolithiasis in postmenopausal women supplemented with calcium or combined calcium and estrogen.
Domrongkitchaiporn S; Ongphiphadhanakul B; Stitchantrakul W; Chansirikarn S; Puavilai G; Rajatanavin R
Maturitas; 2002 Feb; 41(2):149-56. PubMed ID: 11836046
[TBL] [Abstract][Full Text] [Related]
6. Enteric hyperoxaluria secondary to small bowel resection: use of computer simulation to characterize urinary risk factors for stone formation and assess potential treatment protocols.
Rodgers AL; Allie-Hamdulay S; Jackson GE; Sutton RA
J Endourol; 2014 Aug; 28(8):985-94. PubMed ID: 24773381
[TBL] [Abstract][Full Text] [Related]
7. Is calcium oxalate nucleation in postprandial urine of males with idiopathic recurrent calcium urolithiasis related to calcium phosphate nucleation and the intensity of stone formation? Studies allowing insight into a possible role of urinary free citrate and protein.
Schwille PO; Schmiedl A; Manoharan M
Clin Chem Lab Med; 2004 Mar; 42(3):283-93. PubMed ID: 15080561
[TBL] [Abstract][Full Text] [Related]
8. Evaluation and Management of Hypoparathyroidism Summary Statement and Guidelines from the Second International Workshop.
Khan AA; Bilezikian JP; Brandi ML; Clarke BL; Gittoes NJ; Pasieka JL; Rejnmark L; Shoback DM; Potts JT; Guyatt GH; Mannstadt M
J Bone Miner Res; 2022 Dec; 37(12):2568-2585. PubMed ID: 36054621
[TBL] [Abstract][Full Text] [Related]
9. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
[TBL] [Abstract][Full Text] [Related]
10. Acute and 3-month effects of microcrystalline hydroxyapatite, calcium citrate and calcium carbonate on serum calcium and markers of bone turnover: a randomised controlled trial in postmenopausal women.
Bristow SM; Gamble GD; Stewart A; Horne L; House ME; Aati O; Mihov B; Horne AM; Reid IR
Br J Nutr; 2014 Nov; 112(10):1611-20. PubMed ID: 25274192
[TBL] [Abstract][Full Text] [Related]
11. Safety and Efficacy of PTH 1-34 and 1-84 Therapy in Chronic Hypoparathyroidism: A Meta-Analysis of Prospective Trials.
Puliani G; Hasenmajer V; Simonelli I; Sada V; Pofi R; Minnetti M; Cozzolino A; Napoli N; Pasqualetti P; Gianfrilli D; Isidori AM
J Bone Miner Res; 2022 Jul; 37(7):1233-1250. PubMed ID: 35485213
[TBL] [Abstract][Full Text] [Related]
12. Safety and Efficacy of Oral Human Parathyroid Hormone (1-34) in Hypoparathyroidism: An Open-Label Study.
Ish-Shalom S; Caraco Y; Khazen NS; Gershinsky M; Szalat A; Schwartz P; Arbit E; Galitzer H; Tang JC; Burshtein G; Rothner A; Raskin A; Blum M; Fraser WD
J Bone Miner Res; 2021 Jun; 36(6):1060-1068. PubMed ID: 33666947
[TBL] [Abstract][Full Text] [Related]
13. The relationship of 3' vitamin D receptor haplotypes to urinary supersaturation of calcium oxalate salts and to age at onset and familial prevalence of nephrolithiasis.
Mossetti G; Rendina D; Viceconti R; Manno G; Guadagno V; Strazzullo P; Nunziata V
Nephrol Dial Transplant; 2004 Sep; 19(9):2259-65. PubMed ID: 15213319
[TBL] [Abstract][Full Text] [Related]
14. Effect of calcium citrate vs calcium carbonate on elevated parathyroid hormone after Roux-en-Y gastric bypass. A double-blinded, randomized trial.
Ring Madsen L; Espersen R; Rejnmark L; Richelsen B
Clin Endocrinol (Oxf); 2018 Dec; 89(6):734-741. PubMed ID: 30107042
[TBL] [Abstract][Full Text] [Related]
15. Calcium citrate: from biochemistry and physiology to clinical applications.
Palermo A; Naciu AM; Tabacco G; Manfrini S; Trimboli P; Vescini F; Falchetti A
Rev Endocr Metab Disord; 2019 Sep; 20(3):353-364. PubMed ID: 31643038
[TBL] [Abstract][Full Text] [Related]
16. Effect of citrate on the urinary excretion of calcium and oxalate: relevance to calcium oxalate nephrolithiasis.
Cowley DM; McWhinney BC; Brown JM; Chalmers AH
Clin Chem; 1989 Jan; 35(1):23-8. PubMed ID: 2910576
[TBL] [Abstract][Full Text] [Related]
17. [Either calcium carbonate or sevelamer decreases urinary oxalate excretion in chronic renal failure patients].
Caravaca F; Ruiz AB; Escola JM; Hernández Gallego R; Cerezo I; Fernández N; Barroso S; Martín MV
Nefrologia; 2007; 27(4):466-71. PubMed ID: 17944584
[TBL] [Abstract][Full Text] [Related]
18. Management of Hypoparathyroidism.
Khan AA; Guyatt G; Ali DS; Bilezikian JP; Collins MT; Dandurand K; Mannstadt M; Murphy D; M'Hiri I; Rubin MR; Sanders R; Shrayyef M; Siggelkow H; Tabacco G; Tay YD; Van Uum S; Vokes T; Winer KK; Yao L; Rejnmark L
J Bone Miner Res; 2022 Dec; 37(12):2663-2677. PubMed ID: 36161671
[TBL] [Abstract][Full Text] [Related]
19. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
20. Suppression of parathyroid hormone and bone resorption by calcium carbonate and calcium citrate in postmenopausal women.
Thomas SD; Need AG; Tucker G; Slobodian P; O'Loughlin PD; Nordin BE
Calcif Tissue Int; 2008 Aug; 83(2):81-4. PubMed ID: 18553042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
